Notice: This company has been marked as potentially delisted and may not be actively trading. Edge Therapeutics (EDGE) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sharp Therapeutics Corp. Announces Completion of Qualifying TransactionDecember 12, 2024 | finance.yahoo.comAsimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell lineNovember 25, 2024 | msn.comMyeloid Therapeutics to Participate in Jefferies London Healthcare ConferenceNovember 14, 2024 | finance.yahoo.comNeumora Therapeutics, Inc.: Strategic Advancements and Unique Efficacy in MDD Trials Drive Buy RatingNovember 14, 2024 | markets.businessinsider.comA Closer Look at 8 Analyst Recommendations For Amicus TherapeuticsNovember 13, 2024 | benzinga.comAmicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)November 13, 2024 | benzinga.comThe Women’s Edge and The Boston Globe Again Name CCC to Top 100 Women-Led Businesses in Massachusetts ListNovember 13, 2024 | finance.yahoo.comPositive Progress and Promising Prospects: Jack Allen’s Buy Rating on Allogene TherapeuticsNovember 11, 2024 | markets.businessinsider.comSarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For ThursdayNovember 7, 2024 | benzinga.comPeeling Back The Layers: Exploring Amicus Therapeutics Through Analyst InsightsNovember 7, 2024 | benzinga.comPromising Developments and Strategic Advancements in Denali Therapeutics’ Pipeline Boost Andrew Fein’s RatingNovember 7, 2024 | markets.businessinsider.comCentury Therapeutics to Present Cutting-Edge Preclinical Data at 2024 ASH Annual MeetingNovember 7, 2024 | msn.comJP Morgan Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight RecommendationNovember 6, 2024 | msn.comLeerink Partners Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform RecommendationNovember 6, 2024 | msn.comQuell Therapeutics to Participate at Upcoming Healthcare Investor ConferencesNovember 6, 2024 | markets.businessinsider.comInsignis Therapeutics Receives Positive FDA Feedback on IN-001 Clinical Program for Needle-Free Anaphylaxis TreatmentNovember 5, 2024 | markets.businessinsider.comMemo Therapeutics completes enrolment in trial of potravitug for BK viremiaNovember 4, 2024 | msn.comAbbVie and EvolveImmune Therapeutics sign oncology collaborationNovember 1, 2024 | msn.comHalia Therapeutics to Present Promising Data at Obesity Week 2024: HT-6184 Shows Enhanced and Sustained Weight Loss with GLP-1 Agonist CombinationOctober 31, 2024 | finance.yahoo.comCutting Edge Gene TherapyOctober 30, 2024 | time.comCoya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's StudyOctober 29, 2024 | finance.yahoo.comBriumvi’s Promising Rise in the RMS Market: TG Therapeutics’ Edge in Efficacy, Safety, and Market PotentialOctober 29, 2024 | markets.businessinsider.comPromising Developments and Competitive Edge: Jasper Therapeutics’ Buy RatingOctober 29, 2024 | markets.businessinsider.comDementia Associated With Alzheimer’s Disease Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersOctober 28, 2024 | theglobeandmail.comIntellia Therapeutics: Buy Rating Maintained Amid Revised Market Projections and Promising Safety ProfileOctober 25, 2024 | markets.businessinsider.comA Closer Look at Intellia Therapeutics's Options Market DynamicsOctober 25, 2024 | benzinga.comBuy Rating on Spyre Therapeutics: Strong Pipeline and Financial Resilience in IBD MarketOctober 22, 2024 | markets.businessinsider.comOblique Therapeutics announces that NaV 1.8 project is advancing to next stageOctober 22, 2024 | finance.yahoo.comKSQ Therapeutics Appoints John Lepore, M.D., to its Board of DirectorsOctober 22, 2024 | markets.businessinsider.comHuidaGene Therapeutics Appoints TJ Cradick, PhD as Chief Technology Officer to Lead Delivery Science and Genome Editing InnovationsOctober 21, 2024 | finance.yahoo.comNurix Therapeutics’ NX-5948 shows promise in Waldenstrom’s macroglobulinaemia trialOctober 21, 2024 | msn.comFind Therapeutics dosing subjects in study of FTX-101 for chronic optic neuropathyOctober 21, 2024 | msn.comAfter Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third WorkforceOctober 18, 2024 | uk.finance.yahoo.comExpert Systems Announces Key Milestone in Collaboration with Lomond TherapeuticsOctober 16, 2024 | finance.yahoo.comVoyager Therapeutics: Strategic Advancements and Undervalued Potential in NeurogeneticsOctober 16, 2024 | markets.businessinsider.comForecasting The Future: 9 Analyst Projections For Capricor TherapeuticsOctober 9, 2024 | benzinga.comCity Therapeutics launches with $135m Series A fundingOctober 9, 2024 | msn.comAfter Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's StudyOctober 8, 2024 | uk.finance.yahoo.comBayer and MOMA Therapeutics Enter Collaboration and License Agreement in OncologyOctober 8, 2024 | finance.yahoo.comAnalyst Scoreboard: 12 Ratings For Sarepta TherapeuticsOctober 4, 2024 | benzinga.comEliem Therapeutics Changes Name to Climb BioOctober 3, 2024 | finance.yahoo.comCamp4 Therapeutics Targets IPO On Early Positive ResultsOctober 1, 2024 | seekingalpha.comSPIMA Therapeutics Launches to Transform Peptide-Based Immunotherapies and Announces Global Licensing Agreement with SATT AxLRSeptember 30, 2024 | finance.yahoo.comModalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD)September 30, 2024 | finance.yahoo.comIs Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?September 30, 2024 | msn.comThe Analyst Landscape: 7 Takes On Kymera TherapeuticsSeptember 27, 2024 | benzinga.comStock Market Today: Stocks edge lower with PCE inflation data on deckSeptember 27, 2024 | finance.yahoo.comA Closer Look at 10 Analyst Recommendations For Celldex TherapeuticsSeptember 25, 2024 | benzinga.comSage Therapeutics, Inc. (SAGE) Hits 52-Week Lows After Trial Failures, According to Short SellersSeptember 25, 2024 | msn.comViking Therapeutics Unusual Options Activity For September 24September 24, 2024 | benzinga.com Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now EDGE Media Mentions By Week EDGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDGE News Sentiment▼0.000.61▲Average Medical News Sentiment EDGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDGE Articles This Week▼04▲EDGE Articles Average Week Get Edge Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EDGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fulcrum Therapeutics News Today DiaMedica Therapeutics News Today Atai Life Sciences News Today Zentalis Pharmaceuticals News Today Acrivon Therapeutics News Today Aclaris Therapeutics News Today Biomea Fusion News Today XBiotech News Today Verastem News Today LifeVantage News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDGE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edge Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edge Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EDGE Stock Alerts